New Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$29K Hold
874
0.03% 85
2020
Q4
$31K Hold
874
0.02% 84
2020
Q3
$30K Hold
874
0.03% 76
2020
Q2
$29K Hold
874
0.04% 75
2020
Q1
$26K Hold
874
0.05% 65
2019
Q4
$25K Hold
874
0.04% 83
2019
Q3
$23K Buy
874
+2
+0.2% +$51 0.02% 84
2019
Q2
$22K Buy
872
+2
+0.2% +$49 0.04% 85
2019
Q1
$23K Buy
870
+210
+32% +$5.16K 0.06% 85
2018
Q4
$15K Hold
660
0.03% 89
2018
Q3
$16K Hold
660
0.03% 105
2018
Q2
$15K Sell
660
-800
-55% -$19K 0.03% 108
2018
Q1
$36K Hold
1,460
0.09% 77
2017
Q4
$39K Hold
1,460
0.05% 76
2017
Q3
$35K Hold
1,460
0.06% 80
2017
Q2
$25K Hold
1,460
0.05% 98
2017
Q1
$25K Hold
1,460
0.05% 97
2016
Q4
$26K Buy
+1,460
New +$26.5K 0.04% 90

Other funds holding NVO

New Capital Management's NVO Position: Q1 2021 in Review

New Capital Management held its Novo Nordisk (NVO) position steady in Q1 2021 at 874 shares worth $29K. The position accounts for 0.03% of the portfolio, ranked #85.

New Capital Management first reported a position in NVO in Q4 2016 and has held it in 18 quarters since. The position peaked at $39K in Q4 2017. 707 funds tracked by Wall St. Rank hold NVO as of Q1 2021.

  • New Capital Management held 874 shares of Novo Nordisk worth $29K as of Q1 2021.
  • New Capital Management left its Novo Nordisk share count unchanged in Q1 2021.
  • Novo Nordisk made up 0.03% of New Capital Management's portfolio in Q1 2021, its #85 holding.
  • New Capital Management first reported a position in Novo Nordisk in Q4 2016 and has held it in 18 quarters since.
  • New Capital Management's Novo Nordisk position peaked at $39K in Q4 2017.
  • 707 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2021.

Based on New Capital Management's 13F filing for Q1 2021, filed 15 Apr 2021.